Form 8-K - Current report:
SEC Accession No. 0000950170-24-105509
Filing Date
2024-09-11
Accepted
2024-09-11 16:10:35
Documents
12
Period of Report
2024-09-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20240910.htm   iXBRL 8-K 44626
2 EX-16.1 rani-ex16_1.htm EX-16.1 3633
  Complete submission text file 0000950170-24-105509.txt   168079

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20240910.xsd EX-101.SCH 26033
14 EXTRACTED XBRL INSTANCE DOCUMENT rani-20240910_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 241292723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)